- Home
- NAT vs ORGO Comparison
NAT vs ORGO Comparison
Compare NAT & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAT
- ORGO
- Stock Information
- Founded
- NAT 1995
- ORGO 1985
- Country
- NAT Bermuda
- ORGO United States
- Employees
- NAT N/A
- ORGO N/A
- Industry
- NAT Marine Transportation
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- NAT Consumer Discretionary
- ORGO Health Care
- Exchange
- NAT Nasdaq
- ORGO Nasdaq
- Market Cap
- NAT 669.1M
- ORGO 620.3M
- IPO Year
- NAT 1997
- ORGO N/A
- Fundamental
- Price
- NAT $3.22
- ORGO $4.08
- Analyst Decision
- NAT Hold
- ORGO Buy
- Analyst Count
- NAT 1
- ORGO 3
- Target Price
- NAT $3.00
- ORGO $7.33
- AVG Volume (30 Days)
- NAT 3.0M
- ORGO 832.5K
- Earning Date
- NAT 08-28-2025
- ORGO 11-06-2025
- Dividend Yield
- NAT 10.48%
- ORGO N/A
- EPS Growth
- NAT N/A
- ORGO N/A
- EPS
- NAT 0.06
- ORGO N/A
- Revenue
- NAT $301,169,000.00
- ORGO $429,531,000.00
- Revenue This Year
- NAT N/A
- ORGO $2.51
- Revenue Next Year
- NAT $38.51
- ORGO $25.45
- P/E Ratio
- NAT $53.87
- ORGO N/A
- Revenue Growth
- NAT N/A
- ORGO N/A
- 52 Week Low
- NAT $2.13
- ORGO $2.61
- 52 Week High
- NAT $3.83
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- NAT 51.81
- ORGO 37.85
- Support Level
- NAT $3.06
- ORGO $4.12
- Resistance Level
- NAT $3.38
- ORGO $4.40
- Average True Range (ATR)
- NAT 0.10
- ORGO 0.24
- MACD
- NAT -0.01
- ORGO -0.06
- Stochastic Oscillator
- NAT 52.92
- ORGO 14.35
About NAT Nordic American Tankers Limited
Nordic American Tankers Ltd owns and operates double-hull crude oil tankers. It is an international tanker company that owns double-hull Suezmax tankers. It operates vessels in the spot market or on spot market-related charters according to cooperative arrangements with third parties. The company's fleet consists of crude oil tankers, and all of its vessels are employed in the spot market. The company has only one type of vessel - Suezmax crude oil tankers. It operates in markets that are very competitive and based mainly on supply and demand.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.